Annual FCF
-$136.32 M
+$46.13 M+25.28%
December 31, 2023
Summary
- As of February 26, 2025, FBIO annual free cash flow is -$136.32 million, with the most recent change of +$46.13 million (+25.28%) on December 31, 2023.
- During the last 3 years, FBIO annual FCF has fallen by -$45.48 million (-50.06%).
- FBIO annual FCF is now -2295.83% below its all-time high of -$5.69 million, reached on December 31, 2010.
Performance
FBIO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$20.06 M
+$1.78 M+8.15%
September 30, 2024
Summary
- As of February 26, 2025, FBIO quarterly free cash flow is -$20.06 million, with the most recent change of +$1.78 million (+8.15%) on September 30, 2024.
- Over the past year, FBIO quarterly FCF has increased by +$2.72 million (+11.94%).
- FBIO quarterly FCF is now -669.13% below its all-time high of -$2.61 million, reached on June 30, 2011.
Performance
FBIO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$102.28 M
+$2.72 M+2.59%
September 30, 2024
Summary
- As of February 26, 2025, FBIO TTM free cash flow is -$102.28 million, with the most recent change of +$2.72 million (+2.59%) on September 30, 2024.
- Over the past year, FBIO TTM FCF has increased by +$27.28 million (+21.05%).
- FBIO TTM FCF is now -1728.75% below its all-time high of -$5.59 million, reached on March 31, 2011.
Performance
FBIO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
FBIO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.3% | +11.9% | +21.1% |
| 3 y3 years | -50.1% | +52.5% | +23.0% |
| 5 y5 years | -26.0% | +24.7% | -3.8% |
FBIO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2.6% | +25.3% | at high | +67.5% | at high | +47.9% |
| 5 y | 5-year | -50.1% | +25.3% | -8.6% | +67.5% | -14.5% | +47.9% |
| alltime | all time | -2295.8% | +25.3% | -669.1% | +67.5% | -1728.8% | +47.9% |
Fortress Biotech Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.06 M(-8.1%) | -$102.28 M(-2.6%) |
| Jun 2024 | - | -$21.84 M(-14.0%) | -$105.00 M(-11.4%) |
| Mar 2024 | - | -$25.39 M(-27.5%) | -$118.49 M(-13.1%) |
| Dec 2023 | -$136.32 M(-25.3%) | -$35.00 M(+53.6%) | -$136.32 M(+5.2%) |
| Sep 2023 | - | -$22.78 M(-35.5%) | -$129.56 M(-14.2%) |
| Jun 2023 | - | -$35.33 M(-18.3%) | -$151.07 M(-14.9%) |
| Mar 2023 | - | -$43.22 M(+53.1%) | -$177.48 M(-2.7%) |
| Dec 2022 | -$182.46 M(+37.3%) | -$28.23 M(-36.3%) | -$182.46 M(-7.1%) |
| Sep 2022 | - | -$44.29 M(-28.2%) | -$196.42 M(+8.3%) |
| Jun 2022 | - | -$61.73 M(+28.1%) | -$181.37 M(+14.1%) |
| Mar 2022 | - | -$48.20 M(+14.2%) | -$158.94 M(+19.6%) |
| Dec 2021 | -$132.89 M(+46.3%) | -$42.20 M(+44.3%) | -$132.89 M(+17.9%) |
| Sep 2021 | - | -$29.24 M(-25.6%) | -$112.74 M(+2.3%) |
| Jun 2021 | - | -$39.30 M(+77.5%) | -$110.15 M(+23.3%) |
| Mar 2021 | - | -$22.15 M(+0.4%) | -$89.32 M(-1.7%) |
| Dec 2020 | -$90.85 M(-12.9%) | -$22.05 M(-17.2%) | -$90.85 M(-7.8%) |
| Sep 2020 | - | -$26.65 M(+44.2%) | -$98.53 M(+7.2%) |
| Jun 2020 | - | -$18.48 M(-21.9%) | -$91.90 M(-10.3%) |
| Mar 2020 | - | -$23.67 M(-20.4%) | -$102.40 M(-1.9%) |
| Dec 2019 | -$104.36 M(-3.6%) | -$29.74 M(+48.6%) | -$104.36 M(+6.1%) |
| Sep 2019 | - | -$20.01 M(-30.9%) | -$98.31 M(-7.4%) |
| Jun 2019 | - | -$28.98 M(+13.1%) | -$106.19 M(+1.0%) |
| Mar 2019 | - | -$25.63 M(+8.1%) | -$105.14 M(-2.8%) |
| Dec 2018 | -$108.20 M(+26.8%) | -$23.70 M(-15.0%) | -$108.20 M(+0.7%) |
| Sep 2018 | - | -$27.89 M(-0.1%) | -$107.42 M(+1.9%) |
| Jun 2018 | - | -$27.93 M(-2.6%) | -$105.45 M(+3.8%) |
| Mar 2018 | - | -$28.68 M(+25.2%) | -$101.60 M(+19.1%) |
| Dec 2017 | -$85.32 M | -$22.91 M(-11.6%) | -$85.32 M(+4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$25.93 M(+7.7%) | -$81.68 M(+21.9%) |
| Jun 2017 | - | -$24.08 M(+94.2%) | -$67.03 M(+22.9%) |
| Mar 2017 | - | -$12.40 M(-35.7%) | -$54.55 M(-3.1%) |
| Dec 2016 | -$56.32 M(+74.0%) | -$19.27 M(+70.9%) | -$56.32 M(+25.7%) |
| Sep 2016 | - | -$11.28 M(-2.8%) | -$44.82 M(+11.7%) |
| Jun 2016 | - | -$11.60 M(-18.1%) | -$40.12 M(+10.1%) |
| Mar 2016 | - | -$14.16 M(+82.2%) | -$36.44 M(+12.6%) |
| Dec 2015 | -$32.36 M(+98.1%) | -$7.78 M(+18.1%) | -$32.36 M(+15.1%) |
| Sep 2015 | - | -$6.58 M(-16.9%) | -$28.11 M(+15.9%) |
| Jun 2015 | - | -$7.92 M(-21.5%) | -$24.25 M(+19.2%) |
| Mar 2015 | - | -$10.08 M(+185.9%) | -$20.34 M(+24.6%) |
| Dec 2014 | -$16.33 M(-45.3%) | -$3.53 M(+29.7%) | -$16.33 M(-18.1%) |
| Sep 2014 | - | -$2.72 M(-32.3%) | -$19.94 M(-18.2%) |
| Jun 2014 | - | -$4.01 M(-33.9%) | -$24.36 M(-14.3%) |
| Mar 2014 | - | -$6.07 M(-14.8%) | -$28.41 M(-4.8%) |
| Dec 2013 | -$29.83 M(+27.1%) | -$7.13 M(-0.1%) | -$29.83 M(+0.1%) |
| Sep 2013 | - | -$7.14 M(-11.5%) | -$29.81 M(+9.1%) |
| Jun 2013 | - | -$8.07 M(+7.6%) | -$27.32 M(+8.2%) |
| Mar 2013 | - | -$7.49 M(+5.5%) | -$25.26 M(+8.9%) |
| Dec 2012 | -$23.47 M(+58.7%) | -$7.11 M(+52.5%) | -$23.19 M(+17.4%) |
| Sep 2012 | - | -$4.66 M(-22.4%) | -$19.75 M(+9.6%) |
| Jun 2012 | - | -$6.01 M(+10.7%) | -$18.02 M(+23.2%) |
| Mar 2012 | - | -$5.42 M(+48.2%) | -$14.63 M(-1.1%) |
| Dec 2011 | -$14.79 M(+160.0%) | -$3.66 M(+24.8%) | -$14.79 M(+32.9%) |
| Sep 2011 | - | -$2.93 M(+12.5%) | -$11.13 M(+35.8%) |
| Jun 2011 | - | -$2.61 M(-53.4%) | -$8.20 M(+46.6%) |
| Mar 2011 | - | -$5.59 M | -$5.59 M |
| Dec 2010 | -$5.69 M | - | - |
FAQ
- What is Fortress Biotech annual free cash flow?
- What is the all time high annual FCF for Fortress Biotech?
- What is Fortress Biotech annual FCF year-on-year change?
- What is Fortress Biotech quarterly free cash flow?
- What is the all time high quarterly FCF for Fortress Biotech?
- What is Fortress Biotech quarterly FCF year-on-year change?
- What is Fortress Biotech TTM free cash flow?
- What is the all time high TTM FCF for Fortress Biotech?
- What is Fortress Biotech TTM FCF year-on-year change?
What is Fortress Biotech annual free cash flow?
The current annual FCF of FBIO is -$136.32 M
What is the all time high annual FCF for Fortress Biotech?
Fortress Biotech all-time high annual free cash flow is -$5.69 M
What is Fortress Biotech annual FCF year-on-year change?
Over the past year, FBIO annual free cash flow has changed by +$46.13 M (+25.28%)
What is Fortress Biotech quarterly free cash flow?
The current quarterly FCF of FBIO is -$20.06 M
What is the all time high quarterly FCF for Fortress Biotech?
Fortress Biotech all-time high quarterly free cash flow is -$2.61 M
What is Fortress Biotech quarterly FCF year-on-year change?
Over the past year, FBIO quarterly free cash flow has changed by +$2.72 M (+11.94%)
What is Fortress Biotech TTM free cash flow?
The current TTM FCF of FBIO is -$102.28 M
What is the all time high TTM FCF for Fortress Biotech?
Fortress Biotech all-time high TTM free cash flow is -$5.59 M
What is Fortress Biotech TTM FCF year-on-year change?
Over the past year, FBIO TTM free cash flow has changed by +$27.28 M (+21.05%)